H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 74 Citations 33,420 293 World Ranking 884 National Ranking 493
Medicine D-index 81 Citations 39,270 422 World Ranking 9320 National Ranking 5074

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Asthma
  • Disease

Thomas B. Casale mainly investigates Allergy, Immunology, Asthma, Internal medicine and Intensive care medicine. His Allergy research includes themes of Endotype and Atopic dermatitis. Immunology is represented through his Omalizumab, Immunoglobulin E, Allergen, Immunotherapy and Allergen immunotherapy research.

The concepts of his Asthma study are interwoven with issues in Clinical trial, MEDLINE, Quality of life, Guideline and Disease. His Internal medicine study combines topics in areas such as Placebo, Surgery and Placebo-controlled study. Thomas B. Casale has included themes like Alternative medicine, Exhaled nitric oxide, Physical therapy and Nonallergic rhinitis in his Intensive care medicine study.

His most cited work include:

  • An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. (1251 citations)
  • Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision (1065 citations)
  • Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome (791 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Asthma, Immunology, Internal medicine, Allergy and Omalizumab. His Asthma research incorporates elements of Clinical trial, Family medicine, Intensive care medicine, Disease and Physical therapy. In the field of Internal medicine, his study on Randomized controlled trial overlaps with subjects such as In patient.

His Allergy study combines topics from a wide range of disciplines, such as Alternative medicine, Guideline and MEDLINE. His study in Omalizumab is interdisciplinary in nature, drawing from both Monoclonal antibody and Monoclonal. His Placebo study integrates concerns from other disciplines, such as Budesonide, Anesthesia, Surgery, Exacerbation and Adverse effect.

He most often published in these fields:

  • Asthma (40.16%)
  • Immunology (34.08%)
  • Internal medicine (26.37%)

What were the highlights of his more recent work (between 2018-2021)?

  • Asthma (40.16%)
  • Internal medicine (26.37%)
  • Allergy (24.34%)

In recent papers he was focusing on the following fields of study:

Asthma, Internal medicine, Allergy, Family medicine and Intensive care medicine are his primary areas of study. His studies in Asthma integrate themes in fields like Allergen immunotherapy and Clinical trial. He combines subjects such as Gastroenterology, Omalizumab and Placebo with his study of Internal medicine.

His biological study deals with issues like Immunoglobulin E, which deal with fields such as Atopic dermatitis and Eosinophil. His work deals with themes such as Integrated care and Quality of life, which intersect with Family medicine. His studies examine the connections between Intensive care medicine and genetics, as well as such issues in Allergen, with regards to Pharmacotherapy and mHealth.

Between 2018 and 2021, his most popular works were:

  • Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study (70 citations)
  • 2019 ARIA Care pathways for allergen immunotherapy (54 citations)
  • Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology (49 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Asthma

Thomas B. Casale spends much of his time researching Asthma, Family medicine, Allergy, Internal medicine and Intensive care medicine. The study incorporates disciplines such as mHealth, Clinical trial, Visual analogue scale, Integrated care and Allergen immunotherapy in addition to Asthma. His Visual analogue scale research integrates issues from Randomized controlled trial and Quality of life.

He has researched Family medicine in several fields, including Allergists, Oral immunotherapy and Quality of life. His Allergy study is concerned with the larger field of Immunology. His work focuses on many connections between Internal medicine and other disciplines, such as Omalizumab, that overlap with his field of interest in Post-hoc analysis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly.
The Journal of Allergy and Clinical Immunology (2012)

7730 Citations

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision

Jan L. Brożek;Jean Bousquet;Carlos E. Baena-Cagnani;Sergio Bonini.
The Journal of Allergy and Clinical Immunology (2010)

1957 Citations

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

Jan L. Brożek;Jean Bousquet;Ioana Agache;Arnav Agarwal.
The Journal of Allergy and Clinical Immunology (2017)

1948 Citations

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

Helen K. Reddel;D. Robin Taylor;Eric D. Bateman;Louis-Philippe Boulet.
American Journal of Respiratory and Critical Care Medicine (2009)

1251 Citations

Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome

Jan Lötvall;Cezmi A. Akdis;Leonard B. Bacharier;Leif Bjermer.
web science (2011)

1249 Citations

Proceedings of the ATS Workshop on Refractory Asthma Current Understanding, Recommendations, and Unanswered Questions

Sally E. Wenzel;John V. Fahy;Charles Irvin;Stephen P. Peters.
American Journal of Respiratory and Critical Care Medicine (2000)

1201 Citations

Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria

Marcus Maurer;Karin Rosén;Hsin-Ju Hsieh;Sarbjit Saini.
The New England Journal of Medicine (2013)

902 Citations

Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma

Jean Bousquet;Jean Bousquet;Eva Mantzouranis;Alvaro A. Cruz;Nadia Aït-Khaled.
The Journal of Allergy and Clinical Immunology (2010)

845 Citations

International consensus on (ICON) pediatric asthma

N. G. Papadopoulos;H. Arakawa;A. Custovic;J. Gern.
Allergy (2012)

698 Citations

Practical guide to skin prick tests in allergy to aeroallergens

J. Bousquet;J. Bousquet;L. Heinzerling;C. Bachert;N. G. Papadopoulos.
Allergy (2012)

676 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Thomas B. Casale

Jean Bousquet

Jean Bousquet

Inserm : Institut national de la santé et de la recherche médicale

Publications: 220

Pascal Demoly

Pascal Demoly

University of Montpellier

Publications: 169

Giorgio Walter Canonica

Giorgio Walter Canonica

Humanitas University

Publications: 146

Claus Bachert

Claus Bachert

Ghent University

Publications: 142

Cezmi A. Akdis

Cezmi A. Akdis

University of Zurich

Publications: 125

David Price

David Price

University of Aberdeen

Publications: 109

Nikolaos G. Papadopoulos

Nikolaos G. Papadopoulos

University of Manchester

Publications: 107

Peter Hellings

Peter Hellings

KU Leuven

Publications: 106

Marcus Maurer

Marcus Maurer

Charité - University Medicine Berlin

Publications: 106

Sally E. Wenzel

Sally E. Wenzel

University of Pittsburgh

Publications: 102

Graham Roberts

Graham Roberts

University of Southampton

Publications: 98

Giovanni Passalacqua

Giovanni Passalacqua

University of Genoa

Publications: 93

Torsten Zuberbier

Torsten Zuberbier

Charité - University Medicine Berlin

Publications: 84

Christopher E. Brightling

Christopher E. Brightling

University of Leicester

Publications: 84

Moises A. Calderon

Moises A. Calderon

National Institutes of Health

Publications: 84

Ludger Klimek

Ludger Klimek

Ghent University

Publications: 84

Something went wrong. Please try again later.